1. Home
  2. TBBK vs LMAT Comparison

TBBK vs LMAT Comparison

Compare TBBK & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TBBK
  • LMAT
  • Stock Information
  • Founded
  • TBBK 1999
  • LMAT 1983
  • Country
  • TBBK United States
  • LMAT United States
  • Employees
  • TBBK N/A
  • LMAT N/A
  • Industry
  • TBBK Major Banks
  • LMAT Medical/Dental Instruments
  • Sector
  • TBBK Finance
  • LMAT Health Care
  • Exchange
  • TBBK Nasdaq
  • LMAT Nasdaq
  • Market Cap
  • TBBK 2.7B
  • LMAT 2.0B
  • IPO Year
  • TBBK 2004
  • LMAT 2006
  • Fundamental
  • Price
  • TBBK $50.51
  • LMAT $89.08
  • Analyst Decision
  • TBBK Buy
  • LMAT Buy
  • Analyst Count
  • TBBK 3
  • LMAT 6
  • Target Price
  • TBBK $55.00
  • LMAT $92.60
  • AVG Volume (30 Days)
  • TBBK 564.7K
  • LMAT 98.3K
  • Earning Date
  • TBBK 10-24-2024
  • LMAT 10-31-2024
  • Dividend Yield
  • TBBK N/A
  • LMAT 0.72%
  • EPS Growth
  • TBBK 16.52
  • LMAT 47.83
  • EPS
  • TBBK 3.95
  • LMAT 1.67
  • Revenue
  • TBBK $472,015,000.00
  • LMAT $205,621,000.00
  • Revenue This Year
  • TBBK N/A
  • LMAT $15.01
  • Revenue Next Year
  • TBBK $7.05
  • LMAT $9.07
  • P/E Ratio
  • TBBK $12.71
  • LMAT $54.11
  • Revenue Growth
  • TBBK 6.71
  • LMAT 16.06
  • 52 Week Low
  • TBBK $29.92
  • LMAT $45.96
  • 52 Week High
  • TBBK $59.26
  • LMAT $93.32
  • Technical
  • Relative Strength Index (RSI)
  • TBBK 44.27
  • LMAT 55.00
  • Support Level
  • TBBK $45.82
  • LMAT $84.69
  • Resistance Level
  • TBBK $59.26
  • LMAT $92.84
  • Average True Range (ATR)
  • TBBK 2.17
  • LMAT 2.05
  • MACD
  • TBBK -0.96
  • LMAT -0.07
  • Stochastic Oscillator
  • TBBK 35.86
  • LMAT 75.21

About TBBK The Bancorp Inc

The Bancorp Inc is a financial holding company, through its subsidiary it is engaged in specialty lending namely securities-backed lines of credit, vehicle fleet and another equipment leasing, Small Business Administration lending, insurance policy cash value-backed lines of credit and commercial mortgage-backed loans, generated for sale into commercial mortgage-backed securities markets through securitizations. The company deposits and non-interest income are generated in the payments business which consists of issuing, acquiring, and automated clearing house accounts.

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.

Share on Social Networks: